AroCell: Additional study shows use of TK1 concentration

Research Note

2019-09-19

12:42

An additional study on thymidine kinase 1 concentration further demonstrates its use for breast cancer therapay response. The results presented are important for the company to spread awareness of the method.

OB

Oscar Bergman

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.